
Corxel US to go public via merger with Amanat Acquisition, raising $377M to advance oral obesity drugs.
Corxel Pharmaceuticals US and Amanat Acquisition Corp have agreed to merge, creating a publicly traded biopharmaceutical company focused on oral obesity treatments. The deal will raise approximately $377 million, including $300 million from private i...





